article thumbnail

At ASH, doctors acclaim new sickle cell gene therapies, but are cautious on details

Bio Pharma Dive

Uptake of Casgevy and Lyfgenia may be slow despite their dramatic benefit, physicians said, citing complexities in treatment, manufacturing and reimbursement.

article thumbnail

Low-tech – just what the doctor ordered

Scienmag

Low-tech – just what the doctor ordered Credit: University of Leeds/Dr Pete Culmer Low-tech – just what the doctor ordered Medical equipment that can be manufactured at low cost, is simple to use and can be easily maintained will help extend surgery to the 5 billion people worldwide who currently cannot get access to it, […].

Doctors 82
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Eli Lilly inks deal to acquire Nexus manufacturing plant in WI as Mounjaro and Zepbound shortages drag on

Fierce Pharma

As doctors and patients in the U.S. | As doctors and patients in the U.S. grapple with widening shortages of the popular diabetes therapy Mounjaro and its obesity counterpart Zepbound, the maker of the tirzepatide drugs, Eli Lilly, is forging ahead on its quest to expand capacity for its injectable medicines.

Doctors 104
article thumbnail

Doctor invents hybrid mask allowing ENT doctors to see more patients

Scienmag

VA seeking companies to license, manufacture Credit: Dr. Scott Fuller/VA SACRAMENTO, Calif. – An ear, nose, and throat doctor has invented a simple mask design that significantly improves safety during aerosol-generating procedures of the head and neck.

Doctors 95
article thumbnail

FDA turns down Outlook's ophthalmic version of Roche's Avastin over manufacturing, data shortfalls

Fierce Pharma

Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases.

article thumbnail

Guaranteeing the outcomes of provided services is a challenging yet profitable business model for manufacturers

Scienmag

Lauri Korkeamäki’s doctoral dissertation in Management at the University of Vaasa concerns the outcome-based service offerings of equipment manufacturers. Possibly the most renowned example of outcome-based services is […].

article thumbnail

DOJ cracks down on 'largest and most wide-ranging' COVID-19 fraud

Bio Pharma Dive

Defendants, including doctors, medical business executives and fake vaccination card manufacturers, caused nearly $150 million in false billings to federal programs, the DOJ said.

Doctors 141